Prostaglandins in cancer revisited: principles of production, mechanisms of immune regulation, and therapeutic perspectives.

The cyclooxygenase (COX) signaling pathway is frequently dysregulated in cancer, resulting in aberrant production of prostaglandins - a distinct class of bioactive lipids with immunoregulatory functions. One of these factors, prostaglandin E2 (PGE₂),…

Preview only. Read the full abstract at the source